Economic Evaluation of Romiplostim Vs Eltrombopag In The Treatment of Adult Patients With Chronic Immune Thrombocytopenia In Mexico
Abstract
Authors
M Naranjo ME Alva F Carlos
M Naranjo ME Alva F Carlos
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now